BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8235699)

  • 1. Combination therapy for chronic myelogenous leukemia with interferon alfa and other cytokines.
    Kloke O
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):22-3. PubMed ID: 8235699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon therapy for chronic myelogenous leukemia].
    Shibata A; Hashimoto S
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon-alpha therapy in chronic myelogenous leukemia].
    Ohnishi K
    Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
    Ezaki K
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():279-84. PubMed ID: 10895166
    [No Abstract]   [Full Text] [Related]  

  • 5. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of the cytokine network by interferon: a potential mechanism of interferon in chronic myelogenous leukemia.
    Peschel C; Aman MJ; Rudolf G; Aulitzky WE; Huber C
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):28-31. PubMed ID: 8235702
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon therapy in chronic myelogenous leukemia.
    Guilhot F; Roy L; Guilhot J; Millot F
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):585-603, viii. PubMed ID: 15271394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving approaches with interferon alfa in chronic myelogenous leukemia.
    Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Caricchi P
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):26-7. PubMed ID: 8235701
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
    Niederwieser D; Arcese W; Bandini G; Schwaighofer H; Thaler J; Bosi A; Di Bartolomeo P; Alessandrino EP; Urban C; Gratwohl A
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):40-3. PubMed ID: 8235706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stem cell transplantation for chronic myelogenous leukemia].
    Takayama N; Okamoto S
    Rinsho Ketsueki; 2000 Apr; 41(4):283-7. PubMed ID: 10846456
    [No Abstract]   [Full Text] [Related]  

  • 11. Approaches to the treatment of Philadelphia-positive acute lymphoblastic leukemia.
    Grigg AP
    Bone Marrow Transplant; 1993 Nov; 12(5):431-5. PubMed ID: 8298552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
    Popławska-Szczygłowska L; Starzyńska J; Chmarzyńska-Mróz E
    Pol Tyg Lek; 1996 May; 51(19-22):283-4. PubMed ID: 9289711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of chronic myeloid leukemia].
    Freund M
    Internist (Berl); 1993 Jun; 34(6):542-9. PubMed ID: 8335444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Status of recombinant cytokines in treatment of leukemic diseases].
    Geissler K
    Wien Med Wochenschr; 1991; 141(9-10):217-20. PubMed ID: 1949848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changing concept of conventional therapy in chronic myelogenous leukemia].
    Ueda R
    Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mobilization of Ph-negative hematopoietic stem cells using rhG-CSF in patients with chronic myeloid leukemia treated with interferon-alfa. Experience of the Clinic Hospital of Barcelona].
    Carreras E
    Sangre (Barc); 1997 Apr; 42 Suppl 1():24-6. PubMed ID: 9381296
    [No Abstract]   [Full Text] [Related]  

  • 19. The chronic leukemias: current and novel therapeutic approaches.
    Rathore R; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):240-2. PubMed ID: 14582218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
    Hehlmann R; Ansari H; Hasford J; Heimpel H
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):44-8. PubMed ID: 8235707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.